These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10624114)

  • 1. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
    Lewy-Trenda I; Bieńkiewicz M
    Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the nucleolar organizer regions (NORs) in the thyroid follicular tumours. Comparison of the cytological and histopathological examinations.
    Musiatowicz B; Dziecioł J; Augustynowicz A; Miller-Famulska D; Sulik M; Famulski W; Chabowski A; Jabłońska E; Andrzejewicz A; Mielech W; Guzińska-Ostymowicz K
    Rocz Akad Med Bialymst; 1998; 43():186-93. PubMed ID: 9972054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Ki-67 as a proliferative marker in lesions of thyroid.
    Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
    Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practical application of proliferation markers' (MIB-1, PCNA, AgNOR) expression analysis for differential diagnostics of nodular thyroid lesions].
    Lewy-Trenda I; Janczukowicz J; Wierzchniewska-Lawska A
    Wiad Lek; 2006; 59(1-2):32-7. PubMed ID: 16646289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):133-41. PubMed ID: 15757200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
    Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases.
    Ciobanu D; Căruntu ID; Vulpoi C; Florea N; Giuşcă SE
    Rom J Morphol Embryol; 2006; 47(4):323-30. PubMed ID: 17392977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
    Aiad HA; Bashandy MA; Abdou AG; Zahran AA
    Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
    Omar E; Madhavan M; Othman NH
    Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.
    Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y
    Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta Np73 expression in thyroid neoplasms originating from follicular cells.
    Ito Y; Uramoto H; Funa K; Yoshida H; Jikuzono T; Asahi S; Higashiyama T; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Pathology; 2006 Jun; 38(3):205-9. PubMed ID: 16753740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.